trending Market Intelligence /marketintelligence/en/news-insights/trending/LR_wof5yL5Hc8HObZrxK1A2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Thermo Fisher spending $150M to expand US, Italian pharma manufacturing sites

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Thermo Fisher spending $150M to expand US, Italian pharma manufacturing sites

Thermo Fisher Scientific Inc. said it will spend $150 million to expand operations at three pharmaceutical manufacturing plants in Italy and the U.S.

Facilities in Monza and Ferentino, Italy, and Greenville, N.C., are part of the expansion, which is expected to be completed in two years. Thermo Fisher plans to devote extra capacity for sterile liquids, freeze-dried products and commercial manufacturing.

The Waltham, Mass.-based company also plans to equip each of the sites with aseptic filling lines and isolator technology in response to customer requests.

"These investments will help expand our global sterile manufacturing network and meet the increasing demand from customers that rely on our biologics development and manufacturing expertise," Thermo Fisher's President of Pharma Services Michel Lagarde said in a March 18 release.